Skip to content
Screener

Teleflex TFX Contingent consideration fair value adjustments

Contingent consideration fair value adjustments at other companies

Boston Scientific logo
Boston ScientificBSX
-$30M-700%
UFP Technologies logo
UFP TechnologiesUFPT
$0-100%
Artivion logo
ArtivionAORT
$7.97M+204%
Merit Medical Systems logo
Merit Medical SystemsMMSI
——
Stereotaxis logo
StereotaxisSTXS
——

Other financials

Income statement

See full
Revenue$570.3M+28.9%
Gross profit$331.7M+24.8%
Operating income$72.8M-20.1%
Net income$99.7M-18.7%
EPS (diluted)$2.28-17.7%

Balance sheet

See full
Cash & equivalents$316.9M+23.5%
Total debt$3.0B+49.5%
Total equity$2.9B-31.5%
Total assets$6.8B-8.0%

Cash flow

See full
Operating cash flow$91.9M+348%
CapEx$14.0M-49.5%
Free cash flow$77.9M+220%

Valuation

See full
Market cap$5.98B+14.9%
Enterprise value$8.64B+24.6%
P/S2.7×-0.4×

Profitability

See full
Gross margin46.7%-4.5pp
Operating margin2%-14.9pp
Net margin-45.8%-56.9pp
FCF margin7.9%—

Returns & leverage

See full
Return on equity-28.9%-33.2pp
Debt / equity1×+0.6×
Current ratio2.6×+0.2×

Where this comes from

Reported directly by Teleflex in its filing.

Tagged under the XBRL concept us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1.

The source filing: Teleflex’s 10-Q, filed August 6, 2026.

Filed
Aug 6, 2026, 3:08 PM EDT
Fiscal quarter
Q2 FY2026
Calendar quarter
Q2 2026
Accession
0000096943-26-000095
Line itemSix Months Ended / June 30, 2026Six Months Ended / June 29, 2025
Intangible asset amortization expense67,94350,668
Deferred financing costs and debt discount amortization expense2,9761,705
Loss on extinguishment of debt1,150—
Changes in contingent consideration(2,699)14,080
Stock-based compensation12,18212,287
Asset impairment charge—8,117
Gain on non-designated foreign currency forward contracts—(83,532)
Deferred income taxes, net(16,090)(1,935)

Item 1. Financial Statements (Unaudited):

FAQ

What is Teleflex's contingent consideration fair value adjustments?
Teleflex (TFX) reported contingent consideration fair value adjustments of -$67K in Q2 2026.
How has Teleflex's contingent consideration fair value adjustments changed year-over-year?
Teleflex's contingent consideration fair value adjustments decreased by 100.4% year-over-year, from $15.88M to -$67K.
What is the long-term trend for Teleflex's contingent consideration fair value adjustments?
Over 3 years (2022 to 2025), Teleflex's contingent consideration fair value adjustments has grown at a 91.3% compound annual growth rate (CAGR), from $2.35M to $16.45M.
What does contingent consideration fair value adjustments mean?
Contingent consideration fair value adjustments

Ask your AI about Teleflex's contingent consideration fair value adjustments.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude